Find the latest pharmaceutical market place for APIs enquiry about Sufentanil Citrate on PharmaCompass.com.

Sufentanil Citrate API needed in Belarus [ENA21711]

A company that focuses on research, development and manufacturing of OSDs, injectables, solutions and semi-solids in various therapeutic areas is looking for suppliers of Sufentanil Citrate API for commercial purposes. The suppliers must support this enquiry with CoA.

Reply

11 Jan 2025

Sufentanil Citrate API needed in Pakistan [ENA18714]

A company that focuses on distribution of various pharmaceutical products is looking for suppliers of Sufentanil Citrate API for commercial purposes. The required quantity is MOQ. The suppliers must support this enquiry with CoA.

Reply

02 Dec 2023

Sufentanil Citrate (30 g - 50 g) API needed in Algeria [ENA17656]

A large pharmaceutical manufacturing and distribution company that deals in 14 therapeutic classes is looking for suppliers of Sufentanil Citrate (30 g - 50 g) API for development purposes. The suppliers must support this enquiry with DMF or GMP & CoA.

Reply

25 Jul 2023

india-flag Flag

Sufentanyl (1 g) API needed in India [ENA15754]

A CDMO that focuses on injectables, oral solid dosages, prescription drugs, OTC products, dietary supplements and cosmetics is looking for suppliers of Sufentanyl (1 g) API for commercial purposes. The suppliers must support this enquiry with DMF.

Reply

07 Dec 2022

india-flag Flag

Sufentanil Citrate (5 g) API needed in India [ENA13951]

A CDMO that focuses in injectables, oral solid dosages, prescription drugs, OTC products, dietary supplements and cosmetics is looking for suppliers of Sufentanil Citrate (5 g) API for development purpose. The suppliers must support this enquiry with open part DMF.

Reply

13 Jun 2022

Sufentanil Citrate (700 g) API needed in Algeria [ENA05519]

A consultant company based out of Tunisia is looking for suppliers of Sufentanil Citrate (700 g) API for their customer in Algeria. The supplier must support this enquiry with CoA, GMP & DMF.

Reply

21 Oct 2019